Sale of Nanoshield Product Line (Details) - USD ($) |
1 Months Ended | 6 Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 08, 2023 |
Apr. 04, 2023 |
Mar. 17, 2023 |
Dec. 27, 2022 |
Nov. 22, 2022 |
Nov. 09, 2022 |
Nov. 08, 2022 |
Nov. 04, 2022 |
Sep. 06, 2022 |
Sep. 06, 2022 |
Jul. 26, 2022 |
Jul. 26, 2022 |
Jun. 23, 2022 |
Mar. 14, 2022 |
Oct. 15, 2021 |
May 05, 2021 |
Dec. 27, 2022 |
Jun. 30, 2023 |
May 31, 2023 |
May 01, 2023 |
Apr. 30, 2023 |
Apr. 01, 2023 |
|
| Sale of Nanoshield Product Line [Abstract] | ||||||||||||||||||||||
| Purchase Price | $ 4,000,000 | |||||||||||||||||||||
| Net proceeds | $ 50,000 | $ 100,000 | $ 176,000 | $ 176,000 | $ 176,000 | $ 680,000 | $ 60,000 | $ 1,989,755 | ||||||||||||||
| Principal balance | 400,000 | |||||||||||||||||||||
| Accrued interest payable | 310,192 | |||||||||||||||||||||
| Cash payment | $ 200,000 | $ 200,000 | ||||||||||||||||||||
| Issuance shares (in Shares) | 773,626 | 773,626 | 998,008 | 998,008 | 22,000,000 | 22,000,000 | 22,000,000 | 21,371,481 | 21,371,481 | |||||||||||||
| Repaid amount | $ 875,000 | $ 288,035 | $ 288,035 | $ 271,825 | $ 875,000 | $ 288,035 | $ 419,260 | $ 419,260 | $ 419,260 | $ 271,825 | $ 875,000 | |||||||||||
| Sales | $ 4,051,709 | |||||||||||||||||||||
| X | ||||||||||
- Definition Principal balance. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition sale of product. No definition available.
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest payable on debt, including, but not limited to, trade payables. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|